ClinicalTrials.Veeva

Menu

Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture (Delirium-Hip)

A

Aretaieion University Hospital

Status

Enrolling

Conditions

Hip Fractures
Delirium
Mental Status Change
Analgesia
Delirium in Old Age
Pain
Dementia

Treatments

Other: fascia iliaca compartment block with placebo
Other: fascia iliaca compartment block with ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT04404959
Delirium-Pain-Hip Fracture

Details and patient eligibility

About

The objective of this trial will be to establish whether the ultrasound-guided suprainguinal fascia iliaca compartment block is capable of protecting geriatric patients with hip fracture from delirium as compared to placebo

Full description

Geriatric patients suffer from hip fractures very often. Delirium is a perioperative neuropsychiatric complication that is characterized by sudden change of mental status, inattention, disorientation and memory impairment with fluctuations of symptoms during the day. Delirium causes increased morbidity and mortality, decreased postoperative functional activity and may predispose to dementia.

Perioperative pain may be an important predisposing factor to delirium. Intravenous opioids have been widely used to relieve patients with hip fracture from pain, but they have a lot of complications and have been correlated with delirium as well. Fascia Iliaca compartment block is a peripheral compartment nerve block that is used in hip surgeries. Use of this compartment nerve block to protect geriatric patients from delirium has not been studied.

The objective of this trial will be to establish whether the ultrasound-guided suprainguinal fascia iliaca compartment block is capable of protecting geriatric patients with hip fracture from delirium as compared to placebo

Enrollment

80 estimated patients

Sex

All

Ages

75 to 105 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • geriatric patients
  • American Society of Anesthesiologists (ASA) I-III
  • hip fracture patients

Exclusion criteria

  • dementia
  • communication or language barriers
  • patients with nutritional problems
  • bedridden patients

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

80 participants in 2 patient groups, including a placebo group

fascia iliaca compartment block with ropivacaine
Active Comparator group
Description:
in this arm, the fascia iliaca compartment block will be performed with 40 mL ropivacaine 0.25%
Treatment:
Other: fascia iliaca compartment block with ropivacaine
fascia iliaca compartment block with placebo
Placebo Comparator group
Description:
in this arm, the fascia iliaca compartment block will be performed with 40 mL normal saline
Treatment:
Other: fascia iliaca compartment block with placebo

Trial contacts and locations

1

Loading...

Central trial contact

Kassiani Theodoraki, PhD, DESA; Krystallia Vitoula, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems